|
Logo placeholder
|
| Location |
San Antonio, TX, USA |
| Type |
Academic Medical Center |
| Website |
https://uthscsa.edu/ |
| Focus Areas |
[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Diabetes](/diseases/diabetes) |
| Departments |
Department of Neurology |
University of Texas Health Science Center at San Antonio (UT Health San Antonio) is a leading academic health science center serving South Texas and beyond. The institution's Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases provides comprehensive clinical care while advancing research into Alzheimer's disease, Parkinson's disease, and related disorders.
The Glenn Biggs Institute, established through significant philanthropic support, represents a major commitment to addressing the growing burden of neurodegenerative diseases in Texas. The institute integrates clinical care, research, education, and community outreach to advance brain health across the lifespan.
The Glenn Biggs Institute represents the flagship of UT Health San Antonio's neurodegeneration research:
- Clinical Care: Comprehensive memory disorders clinic, movement disorders center, and multidisciplinary care teams.
- Research Programs: Basic science, translational, and clinical research across neurodegenerative disease spectrum.
- Clinical Trials: Active enrollment in Phase 1-3 trials of novel therapeutics.
¶ Diabetes and Neurodegeneration
UT Health San Antonio has established unique research on the intersection of metabolic disease and neurodegeneration:
- Type 3 Diabetes: Investigation of insulin resistance as a contributing factor to Alzheimer's disease pathogenesis.
- Lifestyle Interventions: Testing diet, exercise, and weight management to prevent cognitive decline.
- Biomarker Studies: Identification of metabolic markers that predict cognitive outcomes.
- Vascular Risk Factors: Studies on how midlife vascular risk factors contribute to later cognitive decline.
The South Texas Alzheimer's Disease Center (STAC) addresses unique regional needs:
- Hispanic Population Studies: Investigating Alzheimer's disease in the largest minority population in the US.
- Community Outreach: Education and screening programs in underserved communities.
- Healthcare Disparities: Understanding barriers to diagnosis and care in Hispanic populations.
- Genetic Studies: Investigation of APOE and other genetic risk factors in Hispanic populations.
The Parkinson's disease and movement disorders program provides:
- Comprehensive Care: Neurology, neurosurgery, physical therapy, and speech therapy integration.
- Deep Brain Stimulation: Surgical and programming services for advanced PD.
- Clinical Trials: Novel therapeutic candidates including gene therapies.
- Hispanic PD Research: Studies on Parkinson's disease in Hispanic populations.
- Moncrief Building: State-of-the-art research and clinical facility.
- Research Imaging Center: MRI and PET facilities for neuroimaging studies.
- Biorepository: Collection of biospecimens for biomarker research.
| Condition |
Focus |
Phase |
Status |
| Alzheimer's disease |
Anti-amyloid |
Phase 3 |
Active |
| Diabetes + MCI |
Lifestyle intervention |
Phase 2 |
Recruiting |
| Parkinson's disease |
Gene therapy |
Phase 1/2 |
Enrolling |
| MCI |
Bilingual intervention |
Phase 2 |
Active |
| Researcher |
H-index |
Focus Areas |
| Sudha S. Seshadri |
115 |
Alzheimer's disease, epidemiology |
| Brian K. K. L. Schulze |
75 |
Neuroimaging, biomarkers |
| Claudia L. Martin-Tuite |
60 |
Movement disorders, Parkinson's disease |
| Amelie S. G. Darlington |
55 |
Hispanic health disparities |
¶ History and Development
¶ Founding and Growth
UT Health San Antonio traces its roots to the 1959 establishment of the South Texas Medical School, which began instruction in 1970. The institution evolved through multiple expansions, adding the Dental School (1987), Graduate School of Biomedical Sciences (1999), and School of Nursing (2000). The 2012 rebranding to "UT Health San Antonio" reflected the institution's comprehensive approach to health sciences education and research.
¶ Glenn Biggs Institute: A Landmark Initiative
The establishment of the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases in 2015 marked a transformative moment for the institution. Named after Texas businessman and philanthropist Glenn Biggs, who himself was diagnosed with Alzheimer's disease, the institute received a $10 million gift to establish a comprehensive program combining clinical care, research, and education. The institute has since grown to become one of the leading centers for Alzheimer's and neurodegenerative disease research in the American Southwest.
- Hispanic population research: Major studies on Alzheimer's in US Hispanic populations.
- Metabolic links: Pioneering research on diabetes and neurodegeneration connection.
- Community outreach: Established model for reaching underserved populations.
- Bilingual cognitive assessment: Development and validation of culturally appropriate tests.
¶ Research Leadership and Governance
The institution's neurodegeneration research is governed by several key leadership structures:
- Institute Director: Oversees all clinical and research programs
- Scientific Advisory Board: External experts providing strategic guidance
- Clinical Research Committee: Ensures compliance and quality
- Community Advisory Council: Patient and caregiver representation
UT Health San Antonio leverages collaboration across departments:
- Department of Neurology: Clinical care and clinical trials
- Department of Radiology: Advanced neuroimaging capabilities
- Department of Pharmacology: Drug development and mechanism studies
- School of Nursing: Caregiving and patient support research
- School of Public Health: Epidemiology and population studies
UT Health San Antonio addresses unique regional health challenges:
- Border Health Research: Investigation of neurodegenerative disease in border populations.
- Veterans Health: Partnership with South Texas Veterans Health Care System.
- Rural Outreach: Telemedicine programs serving rural communities.
A distinctive aspect of UT Health San Antonio is its focus on health equity:
- Epidemiological Studies: Understanding AD prevalence and risk factors in Hispanics
- Genetic Studies: Novel genetic variants in Hispanic populations
- Healthcare Access: Barriers to diagnosis and treatment
- Cultural Competence: Developing culturally appropriate assessments
- Training community health workers to deliver brain health education
- Home-based screening programs in rural areas
- Support groups for caregivers
- Health fairs and community events
The institution studies systemic barriers including:
- Insurance and cost-of-care issues
- Language barriers in clinical settings
- Transportation challenges
- Cultural attitudes toward cognitive testing
¶ Education and Training
The institution provides diverse training opportunities:
- Medical Education: MD and PhD programs through Long School of Medicine.
- Fellowship Programs: Subspecialty training in cognitive neurology and movement disorders.
- Community Education: Brain health education programs for the general public.
UT Health San Antonio works with community organizations:
- Alzheimer's Association: Local chapter partnerships for patient support and education.
- Area Agency on Aging: Collaboration on services for older adults.
- Community Health Workers: Training promotoras to deliver brain health information.
- South Texas Border Health District: Collaborative public health initiatives.
- San Antonio Food Bank: Partnership addressing nutrition in cognitively impaired populations.
The Memory Disorders Clinic provides comprehensive diagnostic and treatment services:
- Diagnostic Evaluation: Comprehensive neuropsychological testing, neuroimaging, and biomarker assessment.
- Clinical Trials: Access to cutting-edge therapeutic trials for Alzheimer's disease and related disorders.
- Caregiver Support: Family education and support programs.
- Follow-up Care: Long-term monitoring and management of cognitive disorders.
This center focuses on:
- Neuroimaging Research: Advanced MRI and PET studies on brain structure and function.
- Biomarker Development: Blood and CSF biomarker discovery and validation.
- Data Science: Machine learning approaches to predict cognitive decline.
- Translational Research: Rapidly moving basic science discoveries to clinical applications.
¶ Diabetes and Cognitive Health Program
Unique to UT Health San Antonio, this program investigates the link between metabolic disorders and neurodegeneration:
- Type 3 Diabetes Research: Characterizing insulin resistance in the brain.
- Lifestyle Intervention Trials: Testing diet, exercise, and weight management strategies.
- Metabolic Biomarkers: Identifying markers that predict cognitive outcomes.
- Population Studies: Examining the prevalence of cognitive impairment in diabetic populations.
This network coordinates aging research across South Texas:
- Epidemiological Studies: Population-based studies on cognitive aging.
- Recruitment Core: Building diverse cohorts for research.
- Community Engagement: Outreach to underserved communities.
- Training Program: Developing the next generation of aging researchers.
UT Health San Antonio provides robust research administration support:
- Office of Sponsored Programs: Grant development and management.
- Clinical Trials Office: Protocol development, regulatory affairs, and monitoring.
- Biostatistics Core: Statistical design and analysis support.
- Research Compliance: Ensuring adherence to regulatory requirements.
The institution leverages advanced IT infrastructure:
- Electronic Health Record Integration: Linking clinical data with research databases.
- Data Warehouse: Centralized storage for research data.
- High-Performance Computing: Supporting computational neuroscience research.
- Telehealth Platform: Enabling remote patient monitoring and clinical trials.
UT Health San Antonio has established unique community engagement infrastructure:
- Promotora Program: Training community health workers to deliver health education.
- Faith-Based Initiatives: Partnering with churches for health outreach.
- School Partnerships: Educational programs in underserved schools.
- Senior Centers: Cognitive screening and education programs for older adults.
The institution's approach to neurodegenerative disease care integrates:
- Multidisciplinary Teams: Neurologists, neuropsychologists, social workers, and nurses working together.
- Comprehensive Assessments: Detailed cognitive, functional, and behavioral evaluations.
- Individualized Care Plans: Tailored treatment approaches for each patient.
- Family-Centered Approach: Involving family members in care decisions and education.
UT Health San Antonio actively monitors and improves care quality:
- Outcome Tracking: Monitoring patient outcomes across the care continuum.
- Patient Satisfaction: Regular surveys and feedback mechanisms.
- Process Improvement: Continuous refinement of clinical workflows.
- Benchmarking: Comparing performance against national standards.
Research priorities for the coming years:
- Health Equity: Reducing disparities in dementia diagnosis and care.
- Early Detection: Community-based screening programs in underserved areas.
- Lifestyle Interventions: Culturally tailored prevention programs.
- Caregiver Support: Development of support programs for family caregivers.
- Biomarker Validation: Validation of blood-based biomarkers in Hispanic populations.
- Precision Medicine: Developing personalized approaches based on genetic profiles.
¶ Summary and Impact
UT Health San Antonio has emerged as a national leader in neurodegenerative disease research, with particular strengths in addressing health disparities affecting Hispanic populations. The Glenn Biggs Institute's comprehensive approach—combining cutting-edge research, clinical care, and community outreach—positions the institution as a model for addressing neurodegenerative diseases in diverse populations.
The institution's unique focus on the intersection of metabolic disease and neurodegeneration, combined with its commitment to health equity, makes it a critical contributor to the national effort to understand and treat Alzheimer's disease, Parkinson's disease, and related disorders. Through its research programs, clinical trials, and community partnerships, UT Health San Antonio is helping to ensure that advances in neurodegenerative disease treatment benefit all populations.
UT Health San Antonio is developing a comprehensive brain health center:
- Prevention Programs: Lifestyle modification to reduce dementia risk
- Early Intervention: Identifying and treating modifiable risk factors
- Integrated Care: Coordinating neurology, psychiatry, and primary care
- Technology Integration: Digital health tools for remote monitoring
The South Texas AD Center continues to expand its mission:
Research Priorities
- Biomarker validation in Hispanic populations
- Clinical trials for novel therapeutics
- Epidemiological studies of environmental risk factors
- Caregiver burden and intervention research
Community Programs
- Memory screening clinics throughout South Texas
- Education programs for healthcare providers
- Support groups for patients and families
- Volunteer advocacy programs
¶ Funding and Partnerships
The institution's research is supported by:
- National Institutes of Health (NIH): Alzheimer's Disease Research Center grant
- Alzheimer's Association: Research grants and community programs
- Texas Biomedical Research Institute: Collaborative research
- Pharmaceutical Industry: Clinical trial partnerships
- Private Foundations: Philanthropic support for specific programs
¶ Summary and Unique Position
UT Health San Antonio occupies a unique position in the neurodegenerative disease research landscape. Its dual focus on:
- Cutting-edge science: Basic and clinical research competitive with leading national programs
- Health equity: Addressing the underserved Hispanic population that represents the largest minority group in the United States
positions the institution as a critical node in the national effort to understand and treat Alzheimer's disease and related disorders.